Healthpoint Settles $90M Medicaid Fraud Suit Over Xenaderm

Law360, New York (September 28, 2012, 5:27 PM EDT) -- Healthpoint Ltd. on Friday agreed to settle a whistleblower's False Claims Act allegations it swindled Medicaid out of at least $90 million by improperly billing for bedsore ointment Xenaderm despite the medication's loss of U.S. Food and Drug Administration approval because of perceived ineffectiveness.

Counsel for the Texas company and the federal government, which intervened in the matter along with more than a dozen states, didn’t disclose terms of the deal, which relates to a Healthpoint cream that combines castor oil, an antiseptic called balsam of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States, ex rel v. Actavis Mid-Atlantic, et al


Case Number

1:02-cv-11738

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Judge

Rya W. Zobel

Date Filed

August 29, 2002

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.